Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Dec-19 6:28 AM View:  | Messinger Michael Chief Financial Officer | Contrafect Corp (CFRX) | 13-Dec-19 | Market Purchase | 5,000 | $0.37 | $1,850.00 | 35% 14.09K to 19.09K | 49% |
| 16-Dec-19 6:21 AM View: | Low David N. Director | Contrafect Corp (CFRX) | 13-Dec-19 | Market Purchase | 300,000 | $0.43 | $129,000.00 | 425% 70.55K to 370.55K | 29% |
| 16-Dec-19 6:26 AM View: | Sucoff Cary Director | Contrafect Corp (CFRX) | 13-Dec-19 | Market Purchase | 50,000 | $0.39 | $19,500.00 | 417% 12.0K to 62.0K | 42% |
| 06-Dec-18 4:53 PM View: | Fosun Industrial Co., Ltd 10% Owner | Contrafect Corp (CFRX) | 04-Dec-18 | Market Sale | 600,000 | $2.04 | $1,224,000.00 | (7%) 8.5M to 7.9M | 69% |
| 06-Dec-18 4:51 PM View: | Shanghai Fosun Pharmaceutic... 10% Owner | Contrafect Corp (CFRX) | 04-Dec-18 | Market Sale Duplicate | 600,000 | $2.04 | $1,224,000.00 | (7%) 8.5M to 7.9M | 69% |
| 26-Jul-17 4:44 PM View: | Barer Sol J Director | Contrafect Corp (CFRX) | 25-Jul-17 | Market Purchase | 40,000 | $1.24 | $49,600.00 | 5% 775.93K to 815.93K | (47%) |
| 26-Jul-17 4:48 PM View: | Pomerantz Roger Director | Contrafect Corp (CFRX) | 25-Jul-17 | Market Purchase | 800 | $1.24 | $992.00 | 100% 0 to 0.8K | (47%) |
| 26-Jul-17 4:50 PM View: | Bogdanos Natalie General Counsel | Contrafect Corp (CFRX) | 25-Jul-17 | Market Purchase | 800 | $1.24 | $992.00 | 100% 0 to 0.8K | (47%) |
| 26-Jul-17 4:52 PM View: | Muntner Joshua B SVP Business Development | Contrafect Corp (CFRX) | 25-Jul-17 | Market Purchase | 2,000 | $1.24 | $2,480.00 | 100% 0 to 2.0K | (47%) |
| 26-Jul-17 4:45 PM View: | Low David N. Director | Contrafect Corp (CFRX) | 25-Jul-17 | Market Purchase | 40,000 | $1.24 | $49,600.00 | 131% 30.55K to 70.55K | (47%) |
| 26-Jul-17 4:49 PM View: | Ricciardi Lisa Director | Contrafect Corp (CFRX) | 25-Jul-17 | Market Purchase | 9,600 | $1.24 | $11,904.00 | 100% 0 to 9.6K | (47%) |
| 26-Jul-17 4:51 PM View: | Cassino Cara M Chief Medical Officer | Contrafect Corp (CFRX) | 25-Jul-17 | Market Purchase | 8,000 | $1.24 | $9,920.00 | 100% 0 to 8.0K | (47%) |
| 27-Jul-17 4:29 PM View: | Blech Isaac Director | Contrafect Corp (CFRX) | 25-Jul-17 | Market Purchase | 16,000 | $1.24 | $19,840.00 | 100% 0 to 16.0K | (47%) |
| 26-Jul-17 4:42 PM View: | Gilman Steven C CEO Director | Contrafect Corp (CFRX) | 25-Jul-17 | Market Purchase | 800 | $1.24 | $992.00 | 4% 20.0K to 20.8K | (47%) |
| 26-Jul-17 4:47 PM View: | Otto Michael Director | Contrafect Corp (CFRX) | 25-Jul-17 | Market Purchase | 8,000 | $1.24 | $9,920.00 | 100% 0 to 8.0K | (47%) |
| 26-Jul-17 4:50 PM View: | Sucoff Cary Director | Contrafect Corp (CFRX) | 25-Jul-17 | Market Purchase | 12,000 | $1.24 | $14,880.00 | 100% 0 to 12.0K | (47%) |
| 26-Jul-17 4:52 PM View: | Messinger Michael SVP Finance | Contrafect Corp (CFRX) | 25-Jul-17 | Market Purchase | 800 | $1.24 | $992.00 | 6% 13.29K to 14.09K | (47%) |
| 27-Jul-16 5:18 PM View: | Gilman Steven C CEO Director | Contrafect Corp (CFRX) | 27-Jul-16 | Market Purchase | 20,000 | $2.48 | $49,600.00 | 100% 0 to 20.0K | (73%) |
| 18-Nov-15 9:34 PM View: | Couto Daniel SVP Manufacturing & Facilities | Contrafect Corp (CFRX) | 17-Nov-15 | Market Sale (Planned) | 2,872 | $3.81 | $10,937.20 | (100%) 2.87K to 0 | 82% |
| 04-Nov-15 4:38 PM View: | Couto Daniel SVP Manufacturing & Facilities | Contrafect Corp (CFRX) | 03-Nov-15 | Market Sale (Planned) | 2,867 | $4.23 | $12,134.90 | (50%) 5.74K to 2.87K | 84% |
| 22-Oct-15 5:52 PM View: | Couto Daniel SVP Manufacturing & Facilities | Contrafect Corp (CFRX) | 20-Oct-15 | Market Sale (Planned) | 2,867 | $4.48 | $12,854.20 | (33%) 8.61K to 5.74K | 85% |
| 08-Oct-15 4:43 PM View: | Couto Daniel SVP Manufacturing & Facilities | Contrafect Corp (CFRX) | 06-Oct-15 | Market Sale (Planned) | 2,867 | $4.11 | $11,781.60 | (25%) 11.47K to 8.61K | 84% |
| 22-Sep-15 6:17 PM View: | Couto Daniel SVP Manufacturing & Facilities | Contrafect Corp (CFRX) | 22-Sep-15 | Market Sale (Planned) | 2,867 | $4.76 | $13,644.30 | (21%) 13.64K to 10.77K | 86% |
| 10-Sep-15 4:35 PM View: | Couto Daniel SVP Manufacturing & Facilities | Contrafect Corp (CFRX) | 08-Sep-15 | Market Sale (Planned) | 2,867 | $4.90 | $14,057.50 | (17%) 17.21K to 14.34K | 86% |
| 03-Mar-15 9:35 PM View: | Gregory Julia P CEO | Contrafect Corp (CFRX) | 02-Mar-15 | Market Purchase | 11,778 | $4.61 | $54,296.60 | 31% 38.51K to 50.28K | (85%) |
| 08-Oct-14 2:18 PM View: | Kappel Barry J. SVP Business Development | Contrafect Corp (CFRX) | 11-Sep-14 | Grant | 12,532 | $4.00 | $50,128.00 | 100% 0 to 12.53K | |
| 08-Oct-14 2:21 PM View: | Gregory Julia P CEO | Contrafect Corp (CFRX) | 11-Sep-14 | Grant | 29,946 | $4.00 | $119,784.00 | 350% 8.56K to 38.51K | |
| 08-Oct-14 2:15 PM View: | Dong Nancy VP Controller | Contrafect Corp (CFRX) | 11-Sep-14 | Grant | 6,287 | $4.00 | $25,148.00 | 71% 8.87K to 15.16K | |
| 08-Oct-14 2:19 PM View: | Messinger Michael VP Finance | Contrafect Corp (CFRX) | 11-Sep-14 | Grant | 13,291 | $4.00 | $53,164.00 | 100% 0 to 13.29K | |
| 08-Oct-14 2:22 PM View: | Couto Daniel SVP Manufacturing & Facilities | Contrafect Corp (CFRX) | 11-Sep-14 | Grant | 17,207 | $4.00 | $68,828.00 | 100% 0 to 17.21K | |
| 08-Oct-14 2:16 PM View: | Huang David B. Chief Medical Officer | Contrafect Corp (CFRX) | 11-Sep-14 | Grant | 23,901 | $4.00 | $95,604.00 | 100% 0 to 23.9K | |
| 08-Oct-14 2:20 PM View: | Wittekind Michael G. Chief Scientific Officer | Contrafect Corp (CFRX) | 11-Sep-14 | Grant | 17,893 | $4.00 | $71,572.00 | 100% 0 to 17.89K |
